Genotoxicity of lipid oxidation compounds

Free Radical Biology and Medicine

Volumn 111, Issue , 2017, Pages 244-252

  Eckl, Peter M ^a   Bresgen, Nikolaus ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

4 hydroxy alkenals; 4 oxo alkenals; Acrolein; Alkanals; Alkenals; Genotoxicity; Oxysterols

Indexed keywords

2 ALKENAL DERIVATIVE; 4 HYDROXY ALKENAL DERIVATIVE; 4 HYDROXYNONENAL; 4 OXO 2 NONENAL; 4 OXO ALKENAL DERIVATIVE; ACROLEIN; ALKANAL DERIVATIVE; ALKANE DERIVATIVE; MALONALDEHYDE; MEMBRANE LIPID; OXYSTEROL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 4-HYDROXY-2-NONENAL; ALDEHYDE; HISTONE DEACETYLASE; MUTAGENIC AGENT;

CELL DEATH; COMET ASSAY; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; DNA STRAND BREAKAGE; EPIGENETICS; GENOTOXICITY; HISTONE MODIFICATION; HUMAN; LIPID DEGRADATION; LIPID OXIDATION; LIPID PEROXIDATION; METABOLIC RATE; MUTAGENICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL CULTURE; CHO CELL LINE; CRICETULUS; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; FIBROBLAST; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; LYMPHOCYTE; METABOLISM; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

ACROLEIN; ALDEHYDES; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETULUS; EPIGENESIS, GENETIC; EPITHELIAL CELLS; FIBROBLASTS; HISTONE DEACETYLASES; HUMANS; LIPID PEROXIDATION; LYMPHOCYTES; MUTAGENS; OXYSTEROLS; SALMONELLA TYPHIMURIUM;

EID: 85012893709     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2017.02.002     Document Type: Review

References (164)

1. Benedetti, A., et al. Effects of diffusible products of peroxidation of rat liver microsomal lipids. Biochem. J. 180:2 (1979), 303–312.
2. Frankel, E., Volatile lipid oxidation products. Prog. Lipid Res. 22:1 (1983), 1–33.
3. Esterbauer, H., Aldehydic products of lipid peroxidation. Free Radic. Lipid Peroxidation Cancer, 1982, 101–128.
4. Reis, A., Spickett, C.M., Chemistry of phospholipid oxidation. Biochim. Biophys. Acta (BBA)-Biomembr. 1818:10 (2012), 2374–2387.
5. Esterbauer, H., Schaur, R.J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1 (1990), 81–128.
6. Benedetti, A., Comporti, M., Esterbauer, H., Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta (BBA)-Lipids Lipid Metab. 620:2 (1980), 281–296.
7. Poli, G., Schaur, J.R., 4‐Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50:4‐5 (2000), 315–321.
8. Dwivedi, S., et al. Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep., 2013.
9. Niki, E., Lipid peroxidation: physiological levels and dual biological effects. Free Radic. Biol. Med. 47:5 (2009), 469–484.
10. Burcham, P.C., Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis 13:3 (1998), 287–305.
11. Poli, G., et al. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J. 227:2 (1985), 629–638.
12. Mukai, F.H., Goldstein, B.D., Mutagenicity of malonaldehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science 191:4229 (1976), 868–869.
13. Marnett, L.J., Lipid peroxidation—DNA damage by malondialdehyde. Mutat. Res./Fundam. Mol. Mech. Mutagen. 424:1 (1999), 83–95.
14. Marnett, L.J., Tuttle, M.A., Comparison of the mutagenicities of malondialdehyde and the side products formed during its chemical synthesis. Cancer Res. 40:2 (1980), 276–282.
15. Basu, A.K., Marnett, L.J., Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis 4:3 (1983), 331–333.
16. Marnett, L.J., et al. Naturally occurring carbonyl compounds are mutagens Salmonella tester strain TA104. Mutat. Res./Fundam. Mol. Mech. Mutagen. 148:1 (1985), 25–34.
17. Benamira, M., et al. Induction of mutations by replication of malondialdehyde modified M13 DNA in Escherichia coil: determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced. Carcinogenesis 16:1 (1995), 93–99.
18. Niedernhofer, L.J., et al. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J. Biol. Chem. 278:33 (2003), 31426–31433.
19. Yau, T.M., Mutagenicity and cytotoxicity of malonaldehyde in mammalian cells. Mech. Ageing Dev. 11:2 (1979), 137–144.
20. Bird, R., Draper, H., Basrur, P., Effect of malonaldehyde and acetaldehyde on cultured mammalian cells: production of micronuclei and chromosomal aberrations. Mutat. Res./Genet. Toxicol. 101:3 (1982), 237–246.
21. G. Brambilla, et al., Genotoxic effects of lipid peroxidation products, in Free Radicals in Liver Injury, IRL Press Oxford, 1985, pp. 59–70.
22. Seto, H., et al. Structure of a new modified nucleoside formed by guanosine-malonaldehyde reaction. Chem. Lett. 6 (1981), 707–708.
23. Nair, V., Turner, G.A., Offerman, R.J., Novel adducts from the modification of nucleic acid bases by malondialdehyde. J. Am. Chem. Soc. 106:11 (1984), 3370–3371.
24. Marnett, L.J., et al. Reaction of malondialdehyde with guanine nucleosides: formation of adducts containing oxadiazabicyclononene residues in the base-pairing region. J. Am. Chem. Soc. 108:6 (1986), 1348–1350.
25. Stone, K., Ksebati, M.B., Marnett, L.J., Investigation of the adducts formed by reaction of malondialdehyde with adenosine. Chem. Res. Toxicol. 3:1 (1990), 33–38.
26. Stone, K., Uzieblo, A., Marnett, L.J., Studies of the reaction of malondialdehyde with cytosine nucleosides. Chem. Res. Toxicol. 3:5 (1990), 467–472.
27. Marnett, L.J., Oxy radicals, lipid peroxidation and DNA damage. Toxicology 181 (2002), 219–222.
28. Vaca, C.E., et al. 32P-Postlabelling determination of DNA adducts of malonadlehyde in humans: total white blood cells and breast tissue. Carcinogenesis 16:8 (1995), 1847–1851.
29. Fang, J.-L., et al. Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition. Carcinogenesis 17:5 (1996), 1035–1040.
30. Rouzer, C.A., et al. Analysis of the malondialdehyde-2′-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. Chem. Res. Toxicol. 10:2 (1997), 181–188.
31. Chaudhary, A.K., et al. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science 265:5178 (1994), 1580–1582.
32. Kadlubar, F., et al. Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat. Res./Fundam. Mol. Mech. Mutagen. 405:2 (1998), 125–133.
33. Voitkun, V., Zhitkovich, A., Analysis of DNA–protein crosslinking activity of malondialdehyde in vitro. Mutat. Res./Fundam. Mol. Mech. Mutagen. 424:1 (1999), 97–106.
34. Brambilla, G., et al. Mutagenicity in V79 Chinese hamster cells of n-alkanals produced by lipid peroxidation. Mutagenesis 4:4 (1989), 277–279.
35. Martelli, A., et al. Cytotoxic and genotoxic effects of five n-alkanals in primary cultures of rat and human hepatocytes. Mutat. Res. Lett. 323:3 (1994), 121–126.
36. Canonero, R., et al. Mutation induction in Chinese hamster lung V79 cells by five alk-2-enals produced by lipid peroxidation. Mutat. Res. Lett. 244:2 (1990), 153–156.
37. Eckl, P., Ortner, A., Esterbauer, H., Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat. Res./Fundam. Mol. Mech. Mutagen. 290:2 (1993), 183–192.
38. Feron, V., et al. Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res./Genet. Toxicol. 259:3–4 (1991), 363–385.
39. Dittberner, U., Eisenbrand, G., Zankl, H., Genotoxic effects of the α, β-unsaturated aldehydes 2-trans-butenal, 2-trans-hexenal and 2-trans, 6-cis-rmnonadienal. Mutat. Res./Environ. Mutagen. Relat. Subj. 335:3 (1995), 259–265.
40. Dittberner, U., et al. Genotoxic effects of 2-trans-hexenal in human buccal mucosa cells in vivo. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 390:1 (1997), 161–165.
41. Glei, M., et al. Comet fluorescence in situ hybridization analysis for oxidative stress–induced DNA damage in colon cancer relevant genes. Toxicol. Sci. 96:2 (2007), 279–284.
42. Eder, E., Hoffman, C., Identification and characterization of deoxyguanosine adducts of mutagenic. beta.-alkyl-substituted acrolein congeners. Chem. Res. Toxicol. 6:4 (1993), 486–494.
43. Gölzer, P., et al. (E)-2-Hexenal-Induced DNA Damage and Formation of Cyclic 1, N 2-(1, 3-Propano)-2′-deoxyguanosine Adducts in Mammalian Cells. Chem. Res. Toxicol. 9:7 (1996), 1207–1213.
44. Stout, M.D., et al. Toxicity, DNA binding, and cell proliferation in male F344 rats following short-term gavage exposures to trans-2-hexenal. Toxicol. Pathol. 36:2 (2008), 232–246.
45. Schuler, D., Eder, E., Detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in organs of Fischer 344 rats by a 32P-post-labeling technique. Carcinogenesis 20:7 (1999), 1345–1350.
46. Kiwamoto, R., et al. A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in human including interindividual variation indicates efficient detoxification and a negligible genotoxicity risk. Arch. Toxicol. 87:9 (2013), 1725–1737.
47. Kehrer, J.P., Biswal, S.S., The molecular effects of acrolein. Toxicol. Sci. 57:1 (2000), 6–15.
48. Stevens, J.F., Maier, C.S., Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52:1 (2008), 7–25.
49. Cai, Y., et al. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. Cancer Res. 59:13 (1999), 3059–3063.
50. Uchida, K., et al. Acrolein is a product of lipid peroxidation reaction Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273:26 (1998), 16058–16066.
51. Rudra, P., Krokan, H., Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive-and resistant human tumor cells. Anticancer Res. 19:1A (1998), 461–469.
52. Liu, X.-Y., Zhu, M.-X., Xie, J.-P., Mutagenicity of acrolein and acrolein-induced DNA adducts. Toxicol. Mech. Methods 20:1 (2010), 36–44.
53. Lijinsky, W., Andrews, A., Mutagenicity of vinyl compounds in Salmonella typhimurium. Teratog. Carcinog. Mutagen. 1:3 (1981), 259–267.
54. Foiles, P., Akerkar, S., Chung, F., Application of an immunoassay for cyclic acrolein deoxyguanosine adducts to assess their formation in DNA of Salmonella typhimurium under conditions of mutation induction by acrolein. Carcinogenesis 10:1 (1989), 87–90.
55. Florin, I., et al. Screening of tobacco smoke constituents for mutagenicity using the Ames’ test. Toxicology 15:3 (1980), 219–232.
56. Sasaki, Y., Endo, R., Mutagenicity of aldehydes in Salmonella. Mutat. Res./Environ. Mutagen. Relat. Subj. 54:2 (1978), 251–252.
57. Parent, R.A., Caravello, H.E., San, R.H., Mutagenic activity of acrolein in S. typhimurium and E. coli. J. Appl. Toxicol. 16:2 (1996), 103–108.
58. Hemminki, K., Falck, K., Vainio, H., Comparison of alkylation rates and mutagenicity of directly acting industrial and laboratory chemicals. Arch. Toxicol. 46:3–4 (1980), 277–285.
59. Zimmering, S., et al. Chemical mutagenesis testing in Drosophila. II. Results of 20 coded compounds tested for the National Toxicology Program. Environ. Mutagen. 7:1 (1985), 87–100.
60. Zimmering, S., Mason, J., Valencia, R., Chemical mutagenesis testing in Drosophila. VII. Results of 22 coded compounds tested in larval feeding experiments. Environ. Mol. Mutagen. 14:4 (1989), 245–251.
61. Sierra, L., et al. Acrolein genotoxicity in Drosophila melanogaster. I. Somatic and germinal mutagenesis under proficient repair conditions. Mutat. Res./Genet. Toxicol. 260:3 (1991), 247–256.
62. Barros, A., Sierra, L., Comendador, M., Acrolein genotoxicity in Drosophila melanogaster. III. Effects of metabolism modification. Mutat. Res./Genet. Toxicol. 321:3 (1994), 119–126.
63. Barros, A., Comendador, M., Sierra, L., Acrolein genotoxicity in Drosophila melanogaster. II. Influence of mus201 and mus308 mutations. Mutat. Res./Fundam. Mol. Mech. Mutagen. 306:1 (1994), 1–8.
64. Curren, R.D., et al. Mutagenesis of xeroderma pigmentosum fibroblasts by acrolein. Mutat. Res. Lett. 209:1–2 (1988), 17–22.
65. Parent, R.A., Caravello, H.E., Harbell, J.W., Gene mutation assay of acrolein in the CHO/HGPRT test system. J. Appl. Toxicol. 11:2 (1991), 91–95.
66. Au, W., et al. Cytogenetic toxicity of cyclophosphamide and its metabolites in vitro. Cytogenet. Genome Res. 26:2–4 (1980), 108–116.
67. Galloway, S., et al. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ. Mol. Mutagen. 10:S10 (1987), 1–35.
68. Wilmer, J.L., Erexson, G.L., Kligerman, A.D., Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes. Cancer Res. 50:15 (1990), 4635–4638.
69. Grafström, R.C., et al. Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res. 48:7 (1988), 1717–1721.
70. Kurtz, A.J., Lloyd, R.S., 1, N 2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage. J. Biol. Chem. 278:8 (2003), 5970–5976.
71. Minko, I.G., et al. Mutagenic potential of DNA–peptide crosslinks mediated by acrolein-derived DNA adducts. Mutat. Res./Fundam. Mol. Mech. Mutagen. 637:1 (2008), 161–172.
72. Kuykendall, J.R., Bogdanffy, M.S., Efficiency of DNA-histone crosslinking induced by saturated and unsaturated aldehydes in vitro. Mutat. Res. Lett. 283:2 (1992), 131–136.
73. Kawanishi, M., et al. Molecular analysis of mutations induced by acrolein in human fibroblast cells using supF shuttle vector plasmids. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 417:2 (1998), 65–73.
74. Kozekov, I.D., et al. DNA interchain cross-links formed by acrolein and crotonaldehyde. J. Am. Chem. Soc. 125:1 (2003), 50–61.
75. Kozekov, I.D., et al. Formation of deoxyguanosine cross-links from calf thymus DNA treated with acrolein and 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 23:11 (2010), 1701–1713.
76. Demir, E., et al. Genotoxic analysis of four lipid-peroxidation products in the mouse lymphoma assay. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 726:2 (2011), 98–103.
77. Yang, I.-Y., et al. Genotoxic mechanism for the major acrolein-derived deoxyguanosine adduct in human cells. Chem. Res. Toxicol. 15:2 (2002), 160–164.
78. Wang, H.-T., et al. Mutagenicity and sequence specificity of acrolein-DNA adducts. Chem. Res. Toxicol. 22:3 (2009), 511–517.
79. Kim, S.-I., Pfeifer, G.P., Besaratinia, A., Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells. Cancer Res. 67:24 (2007), 11640–11647.
80. Moghe, A., et al. Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol. Sci. 143:2 (2015), 242–255.
81. Nakamura, T., Yoyomizu, M., Nagamoto, T., Lipid degradation products capable of reacting with amino acid: identification of 4-hydroxy-2-hexenal, 9-formyl methyl-8-nonenoate, and 10-formyl methyl-9-decenoate from autoxidized methyl linolenate 43:9 (1977), 1097–1104.
82. Eckl, P., Esterbauer, H., Genotoxic effects of 4-hydroxyalkenals. Adv. Biosci. 76 (1989), 141–157.
83. Esterbauer, H., Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57:5 (1993), 779S–785S.
84. Poli, G., et al. 4‐Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 28:4 (2008), 569–631.
85. Csala, M., et al. On the role of 4-hydroxynonenal in health and disease. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 1852:5 (2015), 826–838.
86. Hauptlorenz, S., et al. Effects of the lipidperoxidation product 4-hydroxynonenal and related aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells. Biochem. Pharmacol. 34:21 (1985), 3803–3809.
87. Brambilla, G., et al. Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Mutat. Res./Genet. Toxicol. 171:2 (1986), 169–176.
88. Cajelli, E., Ferraris, A., Brambilla, G., Mutagenicity of 4-hydroxynonenal in V79 Chinese hamster cells. Mutat. Res. Lett. 190:2 (1987), 169–171.
89. Emerit, I., Khan, S., Esterbauer, H., Hydroxynonenal, a component of clastogenic factors?. Free Radic. Biol. Med. 10:6 (1991), 371–377.
90. Benamira, M., Marnett, L.J., The lipid peroxidation product 4-hydroxynonenal is a potent inducer of the SOS response. Mutat. Res./DNA Repair 293:1 (1992), 1–10.
91. Esterbauer, H., Zollner, H., Lang, J., Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem. J. 228:2 (1985), 363–373.
92. Esterbauer, H., Eckl, P., Ortner, A., Possible mutagens derived from lipids and lipid precursors. Mutat. Res./Rev. Genet. Toxicol. 238:3 (1990), 223–233.
93. Kowalczyk, P., et al. Long-chain adducts of trans-4-hydroxy-2-nonenal to DNA bases cause recombination, base substitutions and frameshift mutations in M13 phage. Mutat. Res./Fundam. Mol. Mech. Mutagen. 550:1 (2004), 33–48.
94. Nath, R.G., Chung, F.-L., Detection of exocyclic 1, N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc. Natl. Acad. Sci. USA 91:16 (1994), 7491–7495.
95. Wacker, M., Wanek, P., Eder, E., Detection of 1, N 2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats. Chem. Biol. Interact. 137:3 (2001), 269–283.
96. Hu, W., et al. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23:11 (2002), 1781–1789.
97. Wang, H., et al. Site-specific synthesis and reactivity of oligonucleotides containing stereochemically defined 1, N 2-deoxyguanosine adducts of the lipid peroxidation product trans-4-hydroxynonenal. J. Am. Chem. Soc. 125:19 (2003), 5687–5700.
98. Huang, H., et al. DNA cross‐link induced by trans‐4‐hydroxynonenal. Environ. Mol. Mutagen. 51:6 (2010), 625–634.
99. Stone, M.P., et al. Interstrand DNA cross-links induced by α, β-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc. Chem. Res. 41:7 (2008), 793–804.
100. Minko, I.G., et al. Chemistry and biology of DNA containing 1, N 2-deoxyguanosine adducts of the α, β-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem. Res. Toxicol. 22:5 (2009), 759–778.
101. Chen, H.-J.C., Chung, F.-L., Epoxidation of trans-4-hydroxy-2-nonenal by fatty acid hydroperoxides and hydrogen peroxide. Chem. Res. Toxicol. 9:1 (1996), 306–312.
102. Chen, H.-J.C., Chung, F.-L., Formation of etheno adducts in reactions of enals via autoxidation. Chem. Res. Toxicol. 7:6 (1994), 857–860.
103. Nair, J., et al. Etheno DNA-base adducts from endogenous reactive species. Mutat. Res./Fundam. Mol. Mech. Mutagen. 424:1 (1999), 59–69.
104. Chen, H., et al. 2, 3-epoxy-4-hydroxynonanal, a potential lipid peroxidation product for etheno adduct formation, is not a substrate of human epoxide hydrolase. Carcinogenesis 19:5 (1998), 939–943.
105. Chung, F.-L., et al. 2, 3-Epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation. Carcinogenesis 14:10 (1993), 2073–2077.
106. Pandya, G.A., Moriya, M., 1, N 6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry 35:35 (1996), 11487–11492.
107. Barbin, A., Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat. Res./Rev. Mutat. Res. 462:2 (2000), 55–69.
108. Moriya, M., et al. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. USA 91:25 (1994), 11899–11903.
109. Akasaka, S., Guengerich, F.P., Mutagenicity of site-specifically located 1, N 2-ethenoguanine in Chinese hamster ovary cell chromosomal DNA. Chem. Res. Toxicol. 12:6 (1999), 501–507.
110. Nair, J., et al. Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid. Redox Signal. 8:5–6 (2006), 1003–1010.
111. Winter, C.K., Segall, H., Haddon, W.F., Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res. 46:11 (1986), 5682–5686.
112. Long, E.K., Picklo, M.J., Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE…. Free Radic. Biol. Med. 49:1 (2010), 1–8.
113. Grasse, L.D., Lamé, M.W., Segall, H., In vivo covalent binding of trans-4-hydroxy-2-hexenal to rat liver macromolecules. Toxicol. Lett. 29:1 (1985), 43–49.
114. Rindgen, D., et al. Covalent modifications to 2′-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem. Res. Toxicol. 12:12 (1999), 1195–1204.
115. Lee, S.H., Blair, I.A., Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 13:8 (2000), 698–702.
116. Lee, S.H., et al. Characterization of 2′-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem. Res. Toxicol. 13:7 (2000), 565–574.
117. Pollack, M., et al. Characterization of 2′-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product. Chem. Res. Toxicol. 16:7 (2003), 893–900.
118. Lee, S.H., Blair, I.A., Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc. Med. 11:3 (2001), 148–155.
119. Lee, H.P., et al. The essential role of ERK in 4‐oxo‐2‐nonenal‐mediated cytotoxicity in SH‐SY5Y human neuroblastoma cells. J. Neurochem. 108:6 (2009), 1434–1441.
120. Lin, D., et al. 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 18:8 (2005), 1219–1231.
121. Shibata, T., et al. Identification of a lipid peroxidation product as a potential trigger of the p53 pathway. J. Biol. Chem. 281:2 (2006), 1196–1204.
122. Kasai, H., et al. 4-Oxo-2-hexenal, a mutagen formed by OMEGA-3 fat peroxidation, causes DNA adduct formation in mouse organs. Ind. Health 43:4 (2005), 699–701.
123. Maekawa, M., et al. Identification of 4-oxo-2-hexenal and other direct mutagens formed in model lipid peroxidation reactions as dGuo adducts. Chem. Res. Toxicol. 19:1 (2006), 130–138.
124. Kawai, K., Matsuno, K., Kasai, H., Detection of 4-oxo-2-hexenal, a novel mutagenic product of lipid peroxidation, in human diet and cooking vapor. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 603:2 (2006), 186–192.
125. Kasai, H., Kawai, K., 4-Oxo-2-hexenal, a mutagen formed by ω−3 fat peroxidation: occurrence, detection and adduct formation. Mutat. Res./Rev. Mutat. Res. 659:1 (2008), 56–59.
126. Chou, P.-H., et al. Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2 (E)-nonenal and 4-oxo-2 (E)-hexenal in human autopsy tissues. Chem. Res. Toxicol. 23:9 (2010), 1442–1448.
127. Chien, J.-T., Hsu, D.-J., Chen, B.-H., Kinetic model for studying the effect of quercetin on cholesterol oxidation during heating. J. Agric. Food Chem. 54:4 (2006), 1486–1492.
128. Lee, H.-W., Chien, J.-T., Chen, B.-H., Formation of cholesterol oxidation products in marinated foods during heating. J. Agric. Food Chem. 54:13 (2006), 4873–4879.
129. Li, S.X., et al. Storage, heating, and tocopherols affect cholesterol oxide formation in food oils. J. Agric. Food Chem. 44:12 (1996), 3830–3834.
130. Scolari, M., et al. Quantification of cholesterol oxidation products in commercial fish meals and their formation during storage. Aquac. Res. 31:10 (2000), 785–791.
131. Hur, S., Park, G., Joo, S., Formation of cholesterol oxidation products (COPs) in animal products. Food Control 18:8 (2007), 939–947.
132. Niki, E., et al. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem. Biophys. Res. Commun. 338:1 (2005), 668–676.
133. Pikuleva, I.A., Cholesterol-metabolizing cytochromes P450. Drug Metab. Dispos. 34:4 (2006), 513–520.
134. Lütjohann, D., et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA 93:18 (1996), 9799–9804.
135. Diczfalusy, U., Analysis of cholesterol oxidation products in biological samples. J. AOAC Int. 87:2 (2004), 467–473.
136. Brown, A.J., Jessup, W., Oxysterols and atherosclerosis. Atherosclerosis 142:1 (1999), 1–28.
137. Smith, L.L., Smart, V.B., Ansari, G., Mutagenic cholesterol preparations. Mutat. Res./Genet. Toxicol. 68:1 (1979), 23–30.
138. Jusakul, A., et al. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis., 10(1), 2011, 1.
139. Guardiola, F., et al. Biological effects of oxysterols: current status. Food Chem. Toxicol. 34:2 (1996), 193–211.
140. Smith, L.L., Smart, V.B., Gowda, N.M., Mutagenic sterol hydroperoxides. Mutat. Res./Fundam. Mol. Mech. Mutagen. 161:1 (1986), 39–48.
141. Peterson, A., et al. Mutagenic characterization of cholesterol epoxides in Chinese hamster V79 cells. Mutat. Res./Environ. Mutagen. Relat. Subj. 203:5 (1988), 355–366.
142. Sevanian, A., Peterson, A., The cytotoxic and mutagenic properties of cholesterol oxidation products. Food Chem. Toxicol. 24:10 (1986), 1103–1110.
143. Cheng, Y.-W., et al. Cholesterol-3-beta, 5-alpha, 6-beta-triol induced genotoxicity through reactive oxygen species formation. Food Chem. Toxicol. 43:4 (2005), 617–622.
144. J. Woods, N. O′Brien, Investigation of the Potential Genotoxidty of Cholesterol Oxidation Products in Two Mammalian Fibroblast Cell Lines, 1998.
145. Berhane, K., et al. Detoxification of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. USA 91:4 (1994), 1480–1484.
146. Cheng, J.-Z., et al. Two distinct 4-hydroxynonenal metabolizing glutathione S-transferase isozymes are differentially expressed in human tissues. Biochem. Biophys. Res. Commun. 282:5 (2001), 1268–1274.
147. Ebert, M.N., et al. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24:10 (2003), 1637–1644.
148. Knoll, N., et al. Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol. Sci. 86:1 (2005), 27–35.
149. Steiner, C., et al. Genistein protects human mammary epithelial cells from benzo (a) pyrene-7, 8-dihydrodiol-9, 10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system. Carcinogenesis 28:3 (2006), 738–748.
150. Guyonnet, D., et al. Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 495:1 (2001), 135–145.
151. Fiander, H., Schneider, H., Dietary ortho phenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: the alleviation of oxidative stress and the detoxification of mutagenic xenobiotics. Cancer Lett. 156:2 (2000), 117–124.
152. Apáti, P., et al. In‐vitro effect of flavonoids from Solidago canadensis extract on glutathione S‐transferase. J. Pharm. Pharmacol. 58:2 (2006), 251–256.
153. Lin, Y.-L., et al. Hypolipidemic effect of green tea leaves through induction of antioxidant and phase II enzymes including superoxide dismutase, catalase, and glutathione S-transferase in rats. J. Agric. Food Chem. 46:5 (1998), 1893–1899.
154. McElhanon, K.E., et al. Gsta4 null mouse embryonic fibroblasts exhibit enhanced sensitivity to oxidants: role of 4-hydroxynonenal in oxidant toxicity. Open J. Apoptosis, 2, 2013, 1.
155. Engle, M.R., et al. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse. Toxicol. Appl. Pharmacol. 194:3 (2004), 296–308.
156. Jung, K.-A., Kwak, M.-K., Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells. Oxid. Med. Cell. Longev., 2013, 2013.
157. Gu, X., et al. Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production. Neurobiol. Aging 34:4 (2013), 1069–1079.
158. Doyle, K., Fitzpatrick, F.A., Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J. Biol. Chem. 285:23 (2010), 17417–17424.
159. Drake, J., et al. 4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease. Neurosci. Lett. 356:3 (2004), 155–158.
160. Alzolibani, A.A., et al. 4-Hydroxy-2-nonenal modified histone-H2A: a possible antigenic stimulus for systemic lupus erythematosus autoantibodies. Cell. Immunol. 284:1 (2013), 154–162.
161. Oe, T., et al. A novel lipid hydroperoxide-derived cyclic covalent modification to histone H4. J. Biol. Chem. 278:43 (2003), 42098–42105.
162. Oe, T., et al. Lipid hydroperoxide-derived modifications of core histones. Cancer Res., 64(7 Supplement), 2004 (p. S1302-S1302).
163. Galligan, J.J., et al. Stable histone adduction by 4-oxo-2-nonenal: a potential link between oxidative stress and epigenetics. J. Am. Chem. Soc. 136:34 (2014), 11864–11866.
164. Nair, J., et al. Identification of 3, N 4-etheno-5-methyl-2′-deoxycytidine in human DNA: a new modified nucleoside which may perturb genome methylation. Chem. Res. Toxicol. 25:1 (2012), 162–169.